Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma
Schatz, Jonathan H.
Wolfe, Andrew L.
Rajasekhar, Vinagolu K.
Pagano, Nen C.
Porco, John A.
Zelenetz, Andrew D.
MetadataShow full item record
Citation (published version)Jonathan H Schatz, Elisa Oricchio, Andrew L Wolfe, Man Jiang, Irina Linkov, Jocelyn Maragulia, Weiji Shi, Zhigang Zhang, Vinagolu K Rajasekhar, Nen C Pagano, John A Porco, Julie Teruya-Feldstein, Neal Rosen, Andrew D Zelenetz, Jerry Pelletier, Hans-Guido Wendel. 2011. "Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma.." J Exp Med, Volume 208, Issue 9, pp. 1799 - 1807.
New anticancer drugs that target oncogenic signaling molecules have greatly improved the treatment of certain cancers. However, resistance to targeted therapeutics is a major clinical problem and the redundancy of oncogenic signaling pathways provides back-up mechanisms that allow cancer cells to escape. For example, the AKT and PIM kinases produce parallel oncogenic signals and share many molecular targets, including activators of cap-dependent translation. Here, we show that PIM kinase expression can affect the clinical outcome of lymphoma chemotherapy. We observe the same in animal lymphoma models. Whereas chemoresistance caused by AKT is readily reversed with rapamycin, PIM-mediated resistance is refractory to mTORC1 inhibition. However, both PIM- and AKT-expressing lymphomas depend on cap-dependent translation, and genetic or pharmacological blockade of the translation initiation complex is highly effective against these tumors. The therapeutic effect of blocking cap-dependent translation is mediated, at least in part, by decreased production of short-lived oncoproteins including c-MYC, Cyclin D1, MCL1, and the PIM1/2 kinases themselves. Hence, targeting the convergence of oncogenic survival signals on translation initiation is an effective alternative to combinations of kinase inhibitors.
RightsCreative Commons License Attribution–Noncommercial–Share Alike 3.0 Unported
Showing items related by title, author, creator and subject.
Whitesell, Luke; Robbins, Nicole; Huang, David S.; McLellan, Catherine A.; Shekhar-Guturja, Tanvi; LeBlanc, Emmanuelle V.; Nation, Catherine S.; Hui, Raymond; Hutchinson, Ashley; Collins, Cathy; Chatterjee, Sharanya; Trilles, Richard; Xie, Jinglin L.; Krysan, Damian J.; Lindquist, Susan; Porco, John A.; Tatu, Utpal; Brown, Lauren E.; Pizarro, Juan; Cowen, Leah E. (Nature Publishing Group, 2019-01-24)
Jin, Caining; Rajabi, Hasan; Rodrigo, Christina M.; Porco, John A.; Kufe, Donald (2013-04-25)The oncogenic MUC1-C subunit is aberrantly overexpressed in most human breast cancers by mechanisms that are not well understood. The present studies demonstrate that stimulation of non- malignant MCF-10A cells with ...
Dokholyan, Nikolay V.; Buldyrev, Sergey V.; Stanley, Harry E.; Shakhnovich, Eugene I. (Academic Press Ltd, 2000-03-10)Molecular dynamics simulations of folding in an off-lattice protein model reveal a nucleation scenario, in which a few well-defined contacts are formed with high probability in the transition state ensemble of conformations. ...